학술논문

Effect of Dose Modifications on Response to Duvelisib in Patients with Relapsed/Refractory (R/R) CLL/SLL in the DUO Trial
Document Type
Abstract
Source
In Clinical Lymphoma, Myeloma and Leukemia September 2019 19 Supplement 1:S273-S274
Subject
Language
ISSN
2152-2650